【Shenzhen Business News】(Reporter Zhao Hongfei Correspondent Shenzhen Third Hospital) On October 23, the launch meeting of the antiviral treatment research (budding) project for children's chronic hepatitis B was held in Shenzhen. The reporter learned from the meeting that there are about 70 million cases of chronic hepatitis B virus infection in China, of which nearly 2 million children are positive for hepatitis B surface antigen.
At present, there is a relative lack of specialized teams for the diagnosis and treatment of chronic hepatitis B in children in China, and there are problems such as insufficient understanding and lack of clinical guidelines, which bring many confusions to children, families and society.
In order to accumulate evidence-based medical evidence for the antiviral treatment of chronic hepatitis B in children and standardize the diagnosis and treatment path of chronic hepatitis B in Chinese children, beijing Chen Jumei Public Welfare Foundation launched the "Bud" project, which was led by the Third People's Hospital of Shenzhen, and the Liver Disease Special Committee of the Chinese Medical Education Association and the Children's Liver Disease Collaboration Group of the Hepatology Branch of the Chinese Medical Association served as academic guidance.
The project is the first large-scale real-world study of antiviral treatment for chronic hepatitis B in children in China, and through the implementation of the project, relying on the Third People's Hospital of Shenzhen, no less than 30 project hospitals have been developed.
Relying on the "Bud" project, on the one hand, reliable and large samples of real-world research data can be obtained through real-world research to benefit children, providing a basis for the treatment and even guidelines for the treatment of chronic hepatitis B in Children in China; on the other hand, children's antiviral therapy classes are carried out nationwide, and a team of doctors specializing in children's chronic hepatitis B antiviral therapy can be trained, so that Children with chronic hepatitis B in China can get rid of the disease as soon as possible.
【Source: Shenzhen Business Daily】
Disclaimer: The copyright of this article belongs to the original author, if there is an error in the source or infringement of your legitimate rights and interests, you can contact us through the mailbox, we will deal with it in a timely manner. Email address: [email protected]